Moreover, our database analysis (Breast Cancer Gene-Expression Miner v3.2) [46] indicates that there is a statistically significant relationship (p < 0.05, r = −0.27) between reduced expression of BRCA1 and reduced expression of NORE1A in Her2+, but not Her− breast cancers. This evidence concerns the gene RASSF5 and breast cancer.